Attila Frigyesi

6PUBLICATIONS
13CO-AUTHORS
Neural engineeringRespiratory diseasesCell physiologySocial epidemiologyNatural language processing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 14, 2025
Aerosolized Dornase Alfa (DNase I) for the Treatment of Severe Respiratory Failure in COVID-19: A Randomized Controlled Trial.

Per Åkesson, Lisa Mellhammar, Magnus Rasmussen

|Aug 25, 2021
Circulating dipeptidyl peptidase 3 on intensive care unit admission is a predictor of organ dysfunction and mortality.

Attila Frigyesi, Maria Lengquist, Martin Spångfors

|Jul 19, 2021
Plasma proenkephalin A 119-159 on intensive care unit admission is a predictor of organ failure and 30-day mortality.

Attila Frigyesi, Lisa Boström, Maria Lengquist

|May 29, 2020
Sepsis is underreported in Swedish intensive care units: A retrospective observational multicentre study.

Maria Lengquist, Oscar H M Lundberg, Martin Spångfors

|Jan 04, 2020
Coagulation tests on admission correlate with mortality and morbidity in general ICU patients: An observational study.

Sigurdur Benediktsson, Claudia Hansen, Attila Frigyesi

Pageof 1